Editorially Independent Content, Supported with Advertising from Allergan XEN, Glaukos iDose & Nova Eye.
John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO
Show Description +
John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO, review the case of a monocular patient with a history of tube shunt surgery and Xen Gel Stent (AbbVie) implantation. She is taking three medications and has significant ocular surface disease (OSD) and worsening visual acuity. The panelists discuss the decision to place an iStent Infinite (Glaukos) and travoprost intracameral implant (iDose, Glaukos), and they comment on potential approaches that can be accessed down the line.
Posted: 9/10/2026
John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO
John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO, review the case of a monocular patient with a history of tube shunt surgery and Xen Gel Stent (AbbVie) implantation. She is taking three medications and has significant ocular surface disease (OSD) and worsening visual acuity. The panelists discuss the decision to place an iStent Infinite (Glaukos) and travoprost intracameral implant (iDose, Glaukos), and they comment on potential approaches that can be accessed down the line.
Posted: 9/10/2026
Please log in to leave a comment.